OpenVSafe by OpenVAERS
Search V-safe

FDD-11311-38352

5 vaccinations 7 coded responses 19 check-ins 7 free-text entries 4 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
495 / MI
Registered
2021-01-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-29
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-31
    Registered in v-safe
  4. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-02-05
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-03-06
    Survey response — day 35, dose 2
    MedDRA: Vitreous detachment — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Vitreous detachment left eye.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-06
    Report sent to call center — day 35, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-07-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-10-01
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  11. 2021-10-01
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  12. 2021-10-02
    Survey response — days 1–6 daily, dose 3
    MedDRA: Musculoskeletal discomfort, Pain in extremity — Feeling: Good · Site: Pain · Headache
    Free text: Sore neck (no pain chin to chest), some malaise. All sx (c arm pain by 5 pm)
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  15. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  16. 2021-10-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  17. 2021-10-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  18. 2021-10-31
    Survey response — day 28, dose 3
    MedDRA: Abdominal pain — Feeling: Fair
    Free text: Increased abdominal pain.
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-11-07
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  20. 2021-12-31
    Survey response — 3 months, dose 3
    MedDRA: Exercise tolerance decreased, Office visit, Oxygen saturation decreased, Presyncope — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Near syncope episode, decreased exercise tolerance, decreased resting SpO2. Needed ECG, stress echo, 7 day heart monitor and D-dimer · Healthcare visit (other): PCP office visit
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-12-31
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2022-01-04
  23. 2022-02-18
    Call successful
    Participant prefers to complete VAERS report online
  24. 2022-04-01
    Survey response — 6 months, dose 3
    MedDRA: Lymphadenopathy, Pelvic discomfort, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Need work up for pelvic fullness and enlarged lymph nodes. · Healthcare visit (other): US testing
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-04-01
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  26. 2022-04-04
  27. 2022-05-11
    Dose 4 — Moderna
  28. 2022-06-10
    Survey response — day 28, dose 4
    MedDRA: Chest discomfort, Palpitations — Feeling: Fair
    Free text: Increased heart palpations and chest tightness.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-09-17
    Dose 5 — Pfizer-BioNTech
  30. 2022-09-23
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  31. 2022-10-24
    Survey response — day 35, dose 5
    MedDRA: Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Pulsatilla tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-10-24
    Report sent to call center — day 35, dose 5
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  33. 2022-10-25
  34. 2022-10-25

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Pfizer-BioNTech
22021-01-29Pfizer-BioNTech
32021-10-01Pfizer-BioNTech Flu
42022-05-11Moderna No
52022-09-17Pfizer-BioNTech No

Call center

4 call center cases

2 successful · 2 unsuccessful

See the call center timeline

Free text

Release 5 — day 35, dose 2

2021-03-06

Symptoms: Vitreous detachment left eye.

Release 9 — days 1–6 daily, dose 3

2021-10-02

Systemic reaction (other): Sore neck (no pain chin to chest), some malaise. All sx (c arm pain by 5 pm)

Release 10 — day 28, dose 3

2021-10-31

Symptoms: Increased abdominal pain.

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Near syncope episode, decreased exercise tolerance, decreased resting SpO2. Needed ECG, stress echo, 7 day heart monitor and D-dimer
Healthcare visit (other): PCP office visit

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: Need work up for pelvic fullness and enlarged lymph nodes.
Healthcare visit (other): US testing

Release 12 — day 28, dose 4

2022-06-10

Symptoms: Increased heart palpations and chest tightness.

Release 12 — day 35, dose 5

2022-10-24

Symptoms: Pulsatilla tinnitus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOUnevaluable event · · ✓
SDAbdominal pain · · ✓
SDChest discomfort · · ✓
SDExercise tolerance decreased · · ✓
SDLymphadenopathy · · ✓
SDOxygen saturation decreased · · ✓
SDPalpitations · · ✓
SDPelvic discomfort · · ✓
SDPresyncope · · ✓
SDTinnitus · · ✓
SDVitreous detachment ✓ ✓ ✓
SROMusculoskeletal discomfort · · ✓
SROPain in extremity · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release